.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Farmers Insurance
US Department of Justice
Dow
Chubb
Argus Health
Moodys
Medtronic
Deloitte
Daiichi Sankyo

Generated: July 27, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Suspension aerosol formulations
Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.
Inventor(s): Schultz; Robert K. (San Diego, CA), Schultz; David W. (St. Paul, MN), Moris; Robert A. (Lino Lakes, MN)
Assignee: 3M Innovative Properties Company (St. Paul, MN)
Filing Date:May 31, 1995
Application Number:08/455,874
Claims:1. A pharmaceutical suspension aerosol formulation comprising: (i) particulate drug; (ii) 1,1,1,2,3,3,3-heptafluoropropane as propellant; and (iii) ethanol in an amount of 5 to about 15 percent by weight, wherein the formulation contains no surfactant.

2. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is micronized.

3. The pharmaceutical suspension aerosol formulation of claim 1, wherein the drug is albuterol sulfate.

4. The pharmaceutical suspension aerosol formulation of claim 1, wherein the drug is pirbuterol acetate.

5. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is selected from the group consisting of formoterol, salmeterol, beclomethasone dipropionate, cromolyn, pirbuterol, albuterol, and pharmaceutically acceptable salts or solvates thereof.

6. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is formoterol or a pharmaceutically acceptable salt or solvate thereof.

7. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is salmeterol or a pharmaceutically acceptable salt or solvate thereof.

8. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is formoterol fumarate.

9. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is albuterol or a pharmaceutically acceptable salt or solvate thereof.

10. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is beclomethasone dipropionate a pharmaceutically acceptable solvate thereof.

11. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is formoterol or a pharmaceutically acceptable salt or solvate thereof.

12. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is cromolyn or a pharmaceutically acceptable salt or solvate thereof.

13. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is pirbuterol or a pharmaceutically acceptable salt or solvate thereof.

14. The pharmaceutical suspension aerosol formulation of claim 1, wherein the particulate drug is disodium cromoglycate.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Covington
Accenture
Deloitte
Johnson and Johnson
Teva
AstraZeneca
Dow
Healthtrust
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot